Management of Community Program for Opioid Pharmacotherapy (CPOP) patients in a hospital setting.
The Community Program for Opioid Pharmacotherapy (CPOP) in Western Australia provides pharmacotherapy treatment for opioid dependence, through community based authorised opioid pharmacotherapy prescribers and public prescribers at Next Step Drug and Alcohol Services.
Opioid pharmacotherapies currently include methadone syrup and solution, buprenorphine sublingual tablets as Subutex® and buprenorphine with naloxone sublingual film as Suboxone®. They are supplied through authorised community pharmacies and at Next Step Drug and Alcohol Services to patients following assessment by an authorised CPOP prescriber.
Commencement in CPOP must be by an authorised CPOP prescriber and requires prior authorisation from the Chief Executive Officer of Health for each patient. When a patient receiving opioid pharmacotherapy is admitted to hospital, continuation of treatment may occur while in hospital, provided it is safe to do so for up to one month. Consultation with the patient’s authorised CPOP prescriber should be sought if dose adjustment is considered necessary.
It is important that the protocol attached is followed. This will reduce the risk to the patient of an overdose occurring.
Enquiries concerning these protocols or for general information on the CPOP, please contact (08) 9222 6812.
Professor Bryant Stokes
DEPARTMENT OF HEALTH WA